Loading clinical trials...
Loading clinical trials...
Comparison of Quality of Life and Changes Experienced by Patients After Epilepsy Surgery, With Long-term Epileptological Objective Results
Epilepsy is one of the most common chronic neurological diseases. According to data from the World Health Organization (WHO), it affects 0.5 to 1% of the population, or around 70 million people world-wide and around 600,000 in France. There are several more or less severe forms of epilepsy depending on the type of epileptic seizures and the frequency of these seizures. About 30% of epileptic patients respond poorly to well-conducted medical treatment, which makes the number of so-called "drug-resistant" patients estimated at between 100,000 and 150,000 patients. Epilepsy surgery is possible in some cases of drug-resistant epilepsy and can lead to complete seizure control. Beyond the impact on the control of seizures, surgery can have an impact on the lives of patients at the psychological, emotional and cognitive level, with consequences on their socio-professional but also personal life. Thus the impact on the daily life of patients after epilepsy surgery can vary greatly from one patient to another and the personal feelings of operated patients do not always seem to correspond to the objective elements collected by doctors. 2.3 The investigators want to retrospectively assess the satisfaction and quality of life of patients operated on for more than 2 years based on their epileptological results (frequency of seizures).
Age
15 - No limit years
Sex
ALL
Healthy Volunteers
No
CHU de Toulouse
Toulouse, France
Start Date
November 30, 2023
Primary Completion Date
December 1, 2024
Completion Date
December 1, 2024
Last Updated
December 18, 2023
160
ESTIMATED participants
Epilepsy Surgery Satisfaction Questionnaire (ESSQ-19)
OTHER
Quality of Life in Epilepsy Inventory (QOLIE-31)
OTHER
Generalized Anxiety Disorder 7 (GAD7)
OTHER
Neurological Disorders Depression Inventory for Epilepsy (NDDI-E)
OTHER
Evaluation of Changes in Daily Life after Epilepsy Surgery (EVOCQUE)
OTHER
Lead Sponsor
University Hospital, Toulouse
NCT06700356
NCT02531880
NCT05871372
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions